Hannah L Holman Barden1, Ian James Baguley2, Melissa Therese Nott3, Christine Chapparo4. 1. Brain Injury Rehabilitation Service, Westmead Hospital, Wentworthville, NSW, Australia; Faculty of Health Sciences, The University of Sydney, Sydney, Australia. Electronic address: hbar1204@uni.sydney.edu.au. 2. Brain Injury Rehabilitation Service, Westmead Hospital, Wentworthville, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia. 3. Brain Injury Rehabilitation Service, Westmead Hospital, Wentworthville, NSW, Australia; School of Community Health, Charles Sturt University, Albury, NSW, Australia. 4. Faculty of Health Sciences, The University of Sydney, Sydney, Australia.
Abstract
OBJECTIVES: To evaluate change in fine motor hand performance and to investigate the relationship between existing clinical measures and dynamic computerized dynamometry (DCD) after botulinum toxin-A (BTX-A) injections for adults with upper limb spasticity. DESIGN: Pretest/posttest clinical intervention study. SETTING: Hospital outpatient spasticity clinics. PARTICIPANTS: A convenience sample of adults (N=28; mean age, 51y) with upper limb spasticity after acquired brain injury. INTERVENTIONS: BTX-A injections for upper limb spasticity management. MAIN OUTCOME MEASURES: DCD protocol using a piezoelectric pinch meter (termed DCD[pinch]); current clinical upper limb measures: Modified Ashworth Scale, Tardieu Scale, Action Research Arm Test, Michigan Hand Outcomes Questionnaire, and Goal Attainment Scale. RESULTS: BTX-A produced a significant change on DCD(pinch) and some current clinical measures, with correlations observed between DCD(pinch) and current clinical measures. CONCLUSIONS: DCD(pinch) sensitively and objectively assessed the effects of BTX-A on upper limb spasticity during a simulated functionally based pinch and release task.
OBJECTIVES: To evaluate change in fine motor hand performance and to investigate the relationship between existing clinical measures and dynamic computerized dynamometry (DCD) after botulinum toxin-A (BTX-A) injections for adults with upper limb spasticity. DESIGN: Pretest/posttest clinical intervention study. SETTING: Hospital outpatientspasticity clinics. PARTICIPANTS: A convenience sample of adults (N=28; mean age, 51y) with upper limb spasticity after acquired brain injury. INTERVENTIONS: BTX-A injections for upper limb spasticity management. MAIN OUTCOME MEASURES: DCD protocol using a piezoelectric pinch meter (termed DCD[pinch]); current clinical upper limb measures: Modified Ashworth Scale, Tardieu Scale, Action Research Arm Test, Michigan Hand Outcomes Questionnaire, and Goal Attainment Scale. RESULTS: BTX-A produced a significant change on DCD(pinch) and some current clinical measures, with correlations observed between DCD(pinch) and current clinical measures. CONCLUSIONS:DCD(pinch) sensitively and objectively assessed the effects of BTX-A on upper limb spasticity during a simulated functionally based pinch and release task.
Authors: Charlotte M W Gaasterland; Marijke C Jansen-van der Weide; Stephanie S Weinreich; Johanna H van der Lee Journal: BMC Med Res Methodol Date: 2016-08-17 Impact factor: 4.615